Eastman Chemical faced a 12% decline in revenue and significant drops in EBIT and net income in Q4 2025. Despite macroeconomic pressures, the company emphasized cost-saving initiatives and strategic progress on its methanolysis facility.
Q4 revenue declined 12% YoY, driven by lower volume and pricing
Adjusted EPS fell to $0.75 from $1.87 in the prior year
Net income dropped significantly to $110M from $337M in Q4 2024
Company returned $500M to shareholders in 2025 via dividends and buybacks
Eastman expects improved financial performance in 2026 driven by cost reductions, improved utilization, innovation from methanolysis, and stable cash flow. However, macroeconomic uncertainty remains a challenge.
Analyze how earnings announcements historically affect stock price performance